Patents by Inventor Greta G. Cary

Greta G. Cary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
    Patent number: 7998507
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: August 16, 2011
    Assignee: Elan Pharma International Ltd.
    Inventors: H. William Bosch, Greta G. Cary, Douglas C. Hovey, Rajeev A. Jain, Laura J. Kline, Elaine Merisko-Liversidge, Kevin D. Ostrander, Niels P. Ryde, Stephen B. Ruddy
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20100329976
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 30, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20100322852
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20100322853
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20080279949
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: May 9, 2008
    Publication date: November 13, 2008
    Inventors: Elaine MERISKO-LIVERSIDGE, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
    Publication number: 20080226732
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: October 30, 2007
    Publication date: September 18, 2008
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Nanoparticulate compositions of angiogenesis inhibitors
    Publication number: 20080220075
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 11, 2008
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta G. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
    Publication number: 20030181411
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: March 20, 2003
    Publication date: September 25, 2003
    Applicant: Elan Pharma International Ltd.
    Inventors: H. William Bosch, Greta G. Cary, Douglas C. Hovey, Rajeev A. Jain, Laura J. Kline, Elaine Merisko-Liversidge, Kevin D. Ostrander